• Explore /
  • Poster
  • / Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine (cape) in patients with stage III colon cancer (CC): Results of Japan Clinical Oncology Group study (JCOG0910).

Randomized phase III study of adjuvant chemotherapy with S-1 versus capecitabine (cape) in patients with stage III colon cancer (CC): Results of Japan Clinical Oncology Group study (JCOG0910).

Abstract Poster

Authors

Tetsuya Hamaguchi

Tetsuya Hamaguchi

Gastrointestinal Medical Oncology Division, National Cancer Center Hospital, Tokyo, Japan

Tetsuya Hamaguchi , Yasuhiro Shimada , Junki Mizusawa , Yusuke Kinugasa , Yukihide Kanemitsu , Masayuki Ohue , Shoichi Fujii , Nobuhiro Takiguchi , Toshimasa Yatsuoka , Yasumasa Takii , Hitoshi Ojima , Hiroyuki Masuko , Yoshiro Kubo , Hideyuki Mishima , Takashi Yamaguchi , HIroyuki Bandou , Toshihiko Sato , Takeshi Kato , Kenichi Nakamura , Haruhiko Fukuda

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2015 ASCO Annual Meeting

Session Type

Poster Discussion Session

Session Title

Gastrointestinal (Colorectal) Cancer

Track

Gastrointestinal Cancer—Colorectal and Anal

Sub Track

Colorectal Cancer

Clinical Trial Registration Number

UMIN000003272

Citation

J Clin Oncol 33, 2015 (suppl; abstr 3512)

DOI

10.1200/jco.2015.33.15_suppl.3512

Abstract #

3512

Poster Bd #

4

Abstract Disclosures

Similar Posters

First Author: Naohiro Tomita

Poster

2015 ASCO Annual Meeting

S-1 as adjuvant chemotherapy for stage III colon cancer: Updated outcomes of ACTS-CC trial.

S-1 as adjuvant chemotherapy for stage III colon cancer: Updated outcomes of ACTS-CC trial.

First Author: Yusuke Kinugasa

First Author: Suganija Lakkunarajah

First Author: David Lau